BioTech Weekly
🔬 This Week’s Top Biotech News 1️⃣ Medicenna Therapeutics Corp – MDNA11 clinical trial update at ESMO-IO 2025 👉 https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced-solid-tumors/ [https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced-solid-tumors/] 2️⃣ Charlotte emerging as a global leader in healthcare innovation and medtech 👉 https://bio.news/state-policy/charlotte-emerging-as-a-global-leader-in-health-care-innovation-and-med-tech/ [https://bio.news/state-policy/charlotte-emerging-as-a-global-leader-in-health-care-innovation-and-med-tech/] 3️⃣ Ventus Therapeutics – First patient dosed in Phase 2 trial of VENT-03 for lupus 👉 https://www.biotech.ca/news/ventus-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-vent-03-a-novel-small-molecule-cgas-inhibitor-in-patients-with-lupus/ [https://www.biotech.ca/news/ventus-therapeutics-announces-first-patient-dosed-in-phase-2-clinical-trial-of-vent-03-a-novel-small-molecule-cgas-inhibitor-in-patients-with-lupus/] 4️⃣ Morphocell Technologies Inc – Completes US$50M Series A 👉 https://www.biotech.ca/news/morphocell-technologies-inc-completes-us50-million-series-a-financing/ [https://www.biotech.ca/news/morphocell-technologies-inc-completes-us50-million-series-a-financing/] 5️⃣ U.S. House passes BIO-backed legislation to increase access to capital 👉 https://bio.news/federal-policy/house-passes-bio-backed-legislation-to-increase-access-to-capital/ [https://bio.news/federal-policy/house-passes-bio-backed-legislation-to-increase-access-to-capital/] 6️⃣ SWCC – Global Biotech Week: science, innovation, community 👉 https://www.biotech.ca/news/swcc-science-writers-global-biotech-week-uniting-science-innovation-and-community/ [https://www.biotech.ca/news/swcc-science-writers-global-biotech-week-uniting-science-innovation-and-community/] 7️⃣ Neurenati Therapeutics Inc – New board and advisory appointments 👉 https://www.biotech.ca/news/neurenati-therapeutics-inc-welcomes-dr-daniel-guay-to-its-board-of-directors-and-dr-carlo-di-lorenzo-to-its-scientific-and-clinical-advisory-board/ [https://www.biotech.ca/news/neurenati-therapeutics-inc-welcomes-dr-daniel-guay-to-its-board-of-directors-and-dr-carlo-di-lorenzo-to-its-scientific-and-clinical-advisory-board/] 8️⃣ BIO-CSBA report on how states attract biotech 👉 https://bio.news/state-policy/bio-csba-report-explains-why-and-how-states-seek-to-attract-biotech/ [https://bio.news/state-policy/bio-csba-report-explains-why-and-how-states-seek-to-attract-biotech/] 9️⃣ 🎧 Podcast – Cracking Cancer’s Code 👉 https://www.labiotech.eu/podcast/cracking-cancers-code-transforming-research-with-novel-cancer-models/ [https://www.labiotech.eu/podcast/cracking-cancers-code-transforming-research-with-novel-cancer-models/] 🔟 Synthetic biology – Manual released for building synthetic genomes 👉 https://phys.org/news/2025-12-genome-scientists-manual-synthetic-life.html [https://phys.org/news/2025-12-genome-scientists-manual-synthetic-life.html] ⚠️ Disclaimer: Some podcast content uses LLMs; please independently verify details. #Biotech #Biotechnology #Science #Innovation #Healthcare #Research
23 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de BioTech Weekly!